거미막낭종 치료 시장 : 유형별, 진단별, 치료 유형별, 최종 용도별, 세계 예측(2024-2032)

Global Arachnoid Cysts Treatment Market size will expand at 5.7% CAGR from 2024 to 2032, due to the growing needs of the geriatric population. Doctors are performing minimally invasive surgeries using advanced imaging techniques to manage the treatment of cysts. They are also developing medications that help reduce symptoms without extensive procedures. Healthcare providers are utilizing more sophisticated diagnostic tools and personalized treatment plans to improve patient outcomes.

Moreover, researchers are investigating new therapies to enhance the quality of life for elderly patients. To The strong focus on improving early detection and treatment to cater to the increasing number of older individuals affected by arachnoid cysts will add to the industry growth. According to WHO, by 2050, the population aged 60 years and older will double leading to increased cases of arachnoid cysts, further necessitating advancements in minimally invasive treatments and personalized care to meet the growing demand among the elderly individuals.

The market is segregated into type, diagnosis, treatment type, end-use, and region.

In terms of type, the spinal arachnoid cysts treatment industry is set to experience growth at a significant rate through 2032. Spinal arachnoid cysts treatment is widely used for enhancing surgical techniques and patient care. Surgeons are performing minimally invasive procedures to remove or drain spinal cysts to reduce recovery time and complications. They are also integrating advanced imaging to better plan and execute surgeries. The increasing advancements in diagnostics and individualized care plans to ensure that patients receive optimal management will favor the segment growth.

By end-use, the arachnoid cysts treatment market from the ambulatory surgical centers segment is projected to rise from 2024 to 2032. These settings provide efficient and less invasive treatments for a variety of conditions by utilizing advanced imaging and minimally invasive techniques to diagnose and treat cysts, located in the brain or spinal cord. With the evolving treatment methods, physicians in ambulatory surgical centers are employing techniques, such as endoscopic fenestration and shunting to relieve symptoms and prevent complications.

Regionally, the Europe arachnoid cysts treatment industry size is projected to depict robust growth between 2024 and 2032 due to increasing healthcare expenditure and the improving patient outcomes. Healthcare providers in the region are allocating more resources to advanced diagnostic and treatment technologies for enabling better management of arachnoid cysts. With the escalating spending, medical facilities are adopting more effective surgical techniques and postoperative care protocols, subsequently driving the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of arachnoid cysts
    • 3.2.1.2 Increasing awareness and diagnosis for arachnoid cysts
    • 3.2.1.3 Development of minimally invasive surgical techniques
    • 3.2.1.4 Advancement in neuroimaging technologies
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High treatment cost
    • 3.2.2.2 Risk of complications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Pipeline analysis
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Intracranial arachnoid cysts
• 5.3 Spinal arachnoid cysts

Chapter 6 Market Estimates and Forecast, By Diagnosis, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 CT scan
• 6.3 MRI scan
• 6.4 Prenatal ultrasound
• 6.5 Other diagnosis

Chapter 7 Market Estimates and Forecast, By Treatment Type, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Endoscopic cysts fenestration
• 7.3 Fenestration
• 7.4 Permanent drainage system surgery

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 B. Braun Melsungen AG
• 10.2 FUJIFILM Sonosite Inc.
• 10.3 GE Healthcare
• 10.4 Integra Life Sciences
• 10.5 Karl Storz
• 10.6 Koninklijke Philips N.V
• 10.7 Medtronic PLC
• 10.8 Siemens Healthineers
• 10.9 Sophysa
• 10.10 Spiegelberg GmbH & Co.